Label: LIQUICAL PLUS- multivitamin liquid

  • Category: HUMAN PRESCRIPTION DRUG LABEL
  • DEA Schedule: None
  • Marketing Status: unapproved drug other

DISCLAIMER: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here.

Drug Label Information

Updated June 12, 2024

If you are a consumer or patient please visit this version.

View All Sections
  • DRUG DESCRIPTION:

    LiquiCal™ Plus
    Rx Only
    Full Prescribing Information

    Sup Fact

    OTHER INGREDIENTS: Agave Tequilana (Tequila Agave) Stem Extract, Aqua (Purified Water), Citric Acid, Orange Flavor, Potassium Sorbate, Xanthan Gum.

  • INDICATIONS:

    LiquiCal™ Plus is indicated for the supplementation of vitamin D3 and essential minerals, including Calcium, Magnesium, and Zinc in a convenient liquid form for easy administration. It supports bone health, muscle function, and the immune system.

  • CLINICAL PHARMACOLOGY

    Vitamin D3 is essential for calcium absorption in the gut and maintaining adequate serum calcium and phosphate concentrations, supporting bone mineralization and immune function.

    Calcium is crucial for the development and maintenance of healthy bones and teeth, as well as muscle function.

    Magnesium is important for muscle and nerve function, blood glucose control, and bone health.

    Zinc supports normal growth and development, immune function, and wound healing.

  • CONTRAINDICATIONS:

    This product is contraindicated in patients with a known hypersensitivity to any of the ingredients. LiquiCal™ Plus is contraindicated in patients with hypercalcemia, malabsorption syndrome, abnormal sensitivity to the toxic effects of vitamin D, and hypervitaminosis D.

  • WARNINGS AND PRECAUTIONS:

    Tell your doctor if you have: kidney problems, thyroid disease. This medication should be used as directed during pregnancy or while breastfeeding. Consult your doctor.

    ADVERSE REACTIONS:

    Adverse reactions are rare but may include gastrointestinal disturbances such as nausea or constipation. If adverse reactions occur, discontinue use and consult a healthcare professional.

    You should call your doctor for medical advice about serious adverse events. To report adverse side effects or to obtain product information, contact PureTek Corporation, at 1-877-921-7873 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.

  • DOSAGE AND ADMINISTRATION:

    Shake well before use.
    For Children 1-3 years: 1-2 teaspoons (5-10 mL) daily
    For Children 4+ years: 1 tablespoon (15 mL) up to 2 times daily


    LiquiCal™ Plus should be administered under the supervision of a licensed healthcare practitioner.

  • HOW SUPPLIED:

    LiquiCal™ Plus is available in a 480 mL white HDPE bottle with NDC 59088-201-31.

  • STORAGE:

    KEEP THIS AND ALL MEDICATIONS OUT OF THE REACH OF CHILDREN.
    Store at 20°-25°C (68°-77°F) [see USP Controlled Room Temperature].
    Protect from heat, light, and moisture.
    Tamper Evident: Do not use if the seal is broken or missing

  • LiquiCal with Magnesium™

    Manufactured in the USA by:
    PureTek Corporation
    Panorama City, CA 91402
    For questions or information call toll-free: 877-921-7873

    Snip

  • INGREDIENTS AND APPEARANCE
    LIQUICAL PLUS 
    multivitamin liquid
    Product Information
    Product TypeHUMAN PRESCRIPTION DRUGItem Code (Source)NDC:59088-201
    Route of AdministrationORAL
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    CHOLECALCIFEROL (UNII: 1C6V77QF41) (CHOLECALCIFEROL - UNII:1C6V77QF41) CHOLECALCIFEROL1200 [iU]  in 1 mL
    ZINC CITRATE (UNII: K72I3DEX9B) (ZINC CATION - UNII:13S1S8SF37) ZINC CATION2.1 mg  in 1 mL
    MAGNESIUM CITRATE (UNII: RHO26O1T9V) (MAGNESIUM CATION - UNII:T6V3LHY838) MAGNESIUM CITRATE72 mg  in 1 mL
    CALCIUM CITRATE (UNII: MLM29U2X85) (CALCIUM CATION - UNII:2M83C4R6ZB) CALCIUM CITRATE252 mg  in 1 mL
    Inactive Ingredients
    Ingredient NameStrength
    POTASSIUM SORBATE (UNII: 1VPU26JZZ4)  
    WATER (UNII: 059QF0KO0R)  
    ANHYDROUS CITRIC ACID (UNII: XF417D3PSL)  
    XANTHAN GUM (UNII: TTV12P4NEE)  
    AGAVE TEQUILANA STEM (UNII: J026JA743Y)  
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:59088-201-31480 mL in 1 BOTTLE; Type 0: Not a Combination Product06/12/2024
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    unapproved drug other06/12/2024
    Labeler - PureTek Corporation (785961046)
View All Sections

Find additional resources

(also available in the left menu)

Safety

Report Adverse Events, FDA Safety Recalls, Presence in Breast Milk

Related Resources

Medline Plus, Clinical Trials, PubMed, Biochemical Data Summary

More Info on this Drug

View Labeling Archives, RxNorm, Get Label RSS Feed, View NDC Code(s)NEW!